Holen Sie sich die Stockscreener-App
0.736
3.79%
-0.029
Handel nachbörslich:
.72
-0.016
-2.17%
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
98.44%
0.00185
|
0.1181 | 0.1625 | 0.2058 | 0.3546 |
| Operating Expenses |
11.03%
3.1192
|
3.5059 | 4.248 | 3.4319 | 4.4516 |
| Benefits Costs and Expenses |
11.40%
2.9743
|
3.357 | 4.0951 | 3.1006 | 4.1384 |
| Costs And Expenses |
11.03%
3.1192
|
3.5059 | 4.248 | 3.4319 | 4.4516 |
| Operating Income/Loss |
7.98%
-3.1174
|
-3.3878 | -4.0856 | -3.226 | -4.097 |
| Income/Loss From Continuing Operations Before Tax |
8.23%
-2.9724
|
-3.2389 | -3.9327 | -2.8948 | -3.7838 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
8.23%
-2.9724
|
-3.2389 | -3.9327 | -2.8948 | -3.7838 |
Net Income/Loss
|
8.23%
-2.9724
|
-3.2389 | -3.9327 | -2.8948 | -3.7838 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4.76%
6.3729
|
6.0833 | 5.9939 | 0.1493 | 5.9398 |
| Diluted Average Shares |
4.76%
6.3729
|
6.0833 | 5.9939 | 0.1493 | 5.9398 |
| Basic Earnings Per Share |
11.32%
-0.47
|
-0.53 | -0.66 | -0.47 | -0.64 |
| Diluted Earnings Per Share |
11.32%
-0.47
|
-0.53 | -0.66 | -0.57 | -0.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):